The mammalian neocortex has a complicated structure, with multiple layers of different types of neurons linked together in microcircuits. Cortical neurons are generated by progenitor divisions at or near the ventricular zone (VZ), then migrate to defined positions in the developing cortical plate (CP) where they differentiate and connect among themselves and to other brain regions. In general, projection neurons arise from the local VZ, below the CP, while interneurons migrate tangentially from the ganglionic eminences (Parnavelas, 2000; Rash and Grove, 2006). The projection neurons are layered in birth order, such that neurons born early in development are below those born later (Takahashi et al., 1999). Correct neuron layering is important: major defects in projection neuron migration may underlie lissencephalies and heterotopias coupled with mental retardation while milder defects are associated with mental disabilities including dyslexia, schizophrenia, epilepsy, and autism spectrum disorders (Bielas et al., 2004; Francis et al., 2006; Romero et al., 2018). A great deal is known about the distinct neuron migration paths and the signals that regulate them but a significant number of patients with developmental disorders lack a diagnosis. It is thus crucial to identify further causes of disease and understand them mechanistically.

Migrating projection neurons have been visualized in fetal mouse brains in which individual neurons have been labeled in utero (Tabata and Nakajima, 2001; Nadarajah and Parnavelas, 2002; Noctor et al., 2004). Migration occurs in distinct phases. First, neurons move radially from the VZ into the lower intermediate zone (IZ). They then become multipolar and despite an apparent irregular movement, move towards the CP (Nadarajah et al., 2003; Tabata and Nakajima, 2003; Noctor et al., 2004; Jossin and Cooper, 2011). When multipolar neurons reach the upper IZ, they become bipolar and traverse the CP by glial-guided locomotion. The lower IZ therefore constitutes a multipolar migration zone (MMZ) and the upper IZ and CP a radial migration zone (RMZ). Movement out of the MMZ is regulated by many signals, which, if disrupted, can lead to altered layering (Cooper, 2014; Kon et al., 2017). One signal that regulates exit from the MMZ is Reelin, an extracellular matrix protein that activates the small GTPases Rap1A and RalA to upregulate surface levels of neural cadherin (NCad, CDH2) (Jossin, 2011; Jossin and Cooper, 2011). Inhibiting Reelin, Rap1 or NCad interferes with the orientation of multipolar neurons, increases sideways and downwards movements, and increases time spent in the MMZ. Defects in multipolar migration may contribute to the altered layering in Reelin mutant mice and humans (Lambert de Rouvroit and Goffinet, 1998; Hong et al., 2000).

Fibroblast growth factors (FGFs) and their receptors (FGFRs) are important during the development of many tissues and for wound healing, tissue repair and metabolism after birth (Beenken and Mohammadi, 2009; Ornitz and Itoh, 2015). There is wide functional redundancy between family members, with specificity conferred by cell-type-specific expression of FGFs and FGFRs and alternative splicing of FGFRs. At the cellular level, FGFRs regulate cell proliferation, migration, differentiation, survival and cell shape. At the molecular level, FGF and heparan sulfate proteoglycan bind to FGFRs and induce FGFR dimerization and activation. Activated FGFRs autophosphorylate on multiple cytoplasmic tyrosine residues, followed by recruitment and phosphorylation of a variety of downstream signaling proteins (Ornitz and Itoh, 2015). Following activation, FGFRs are down-regulated by ubiquitination, endocytosis and lysosomal degradation (Katzmann et al., 2002; Haugsten et al., 2005). Defects in FGFR activation or down-regulation can lead to anomalous signaling and are associated with developmental defects, metabolic disorders and cancer (Wesche et al., 2011; Ornitz and Itoh, 2015).

In addition to FGFs and heparan sulfate, cell surface proteins including neural cadherin (NCad or CDH2), epidermal cadherin (ECad or CDH1), L1 cell adhesion molecule (L1CAM) and neural CAM (NCAM) can also bind to and activate FGFRs (Williams et al., 1994; Williams et al., 2001; Suyama et al., 2002; Brown et al., 2016). Both NCad and FGFRs are highly expressed during the epithelial-mesenchymal transition of cancer cells and their interaction may be important for metastasis. Indeed, tumor cells artificially over-expressing NCad require FGFR activity for metastasis. Nevertheless, the role of NCad-dependent FGFR activation in metastasis pathology remains unclear (Hulit et al., 2007; Qian et al., 2014).

In the developing cerebral cortex FGFR1-3 are expressed in the VZ and MMZ (Iwata and Hevner, 2009; Hébert, 2011) (Allen Institute for Brain Science. Allen Developing Mouse Brain Atlas. Available from: http://developingmouse.brain-map.org/) and FGFRs have been associated with neurodevelopmental diseases including schizophrenia (O'Donovan et al., 2009; Terwisscha van Scheltinga et al., 2013), epilepsy (Coci et al., 2017; Okazaki et al., 2017), autism spectrum disorders (Wentz et al., 2014; Coci et al., 2017) and lissencephaly (Tan and Mankad, 2018), suggesting possible roles in neuron migration. However, analysis of cortical neuron migration in FGFR mutant mice has been inconclusive for two reasons. First, functional redundancy may suppress the phenotypes of loss of function mutants (Beenken and Mohammadi, 2009; Hébert, 2011; Ornitz and Itoh, 2015). Second, FGFRs are needed for developmental steps that occur before migration, such as regional patterning of the cortex, neurogenesis and radial glia differentiation (Shin et al., 2004; Rash and Grove, 2006; Mason, 2007; Kang et al., 2009; Paek et al., 2009). Therefore, the roles of FGFRs in neocortical neuron migration are unclear.

In this paper we report that FGFR1-3 have overlapping functions during the multipolar migration in vivo. FGFRs are required downstream of Rap1 for multipolar cells to orient towards the CP, adopt bipolar morphology, and migrate out of the MMZ. We found that Rap1-dependent NCad upregulation stabilizes FGFRs by inhibiting K27- and K29-linked polyubiquitination and lysosomal degradation and that NCad-FGFR cis interaction (on the same cell) is involved. Consequently, FGFRs accumulate and are activated, resulting in prolonged activation of Erk1/2 when neurons are stimulated in vitro with Reelin. In vivo inhibition of K27-linked polyubiquitination or overexpression of FGFRs rescues the migration of neurons with inhibited Rap1. Inhibition of Erk1/2 activity in the developing cerebral cortex induces a similar phenotype as FGFR or Rap1 inhibition. These data reveal a novel function of FGFRs in cortical projection neuron migration and the control of its activity by ubiquitination and NCad interaction in vivo. To our knowledge, this is the first physiological role for FGFR-NCad interaction during tissue development. Furthermore, we identified FGFRs as mediating Reelin activation of Erk1/2 to control migration during the multipolar phase. These findings provide insights into FGFR mutation-related inherited brain diseases.

Although much is known about the role of FGFRs in apical neural stem cells during neurogenesis and regional patterning of the cortex, the functions and regulation of FGFRs in neuronal migration have not been elucidated. Our findings implicate FGFRs in a signaling pathway that regulates the orientation of projection neuron multipolar migration during the development of the cerebral cortex (see our working model Figure 9b). When FGFRs are inhibited, multipolar neurons accumulate in the multipolar migration zone. This includes a defect in the orientation of multipolar migration with fewer cells facing the CP, followed by a delay in the multipolar to radial morphology transition and a consequent accumulation of cells at the MMZ. Previous studies indicated that the orientation of multipolar migration and the subsequent bipolar morphology transition is triggered by Reelin, or the R3-6 fragment, diffusing from the outer part of the cortex (Jossin et al., 2004; Jossin et al., 2007; Uchida et al., 2009; Jossin and Cooper, 2011). Reelin activates Rap1, and this in turn upregulates NCad on the neuron surface (Jossin and Cooper, 2011). However, the mechanism by which NCad stimulates the multipolar migration was unknown. One possibility was that NCad on migrating neurons engages in homophilic binding interactions with NCad on surrounding cells (Kawauchi et al., 2010; Matsunaga et al., 2017). However, our new evidence leads us to propose a model in which NCad-NCad trans interactions are not required. Instead, NCad binds in cis to FGFRs on the same cell. This cell-autonomous binding inhibits FGFR K27/K29 polyubiquitination and lysosomal degradation, resulting in a large increase in FGFR abundance and prolonged activation of FGFR and Erk1/2 that is required for the multipolar migration. FGFR-dependent Erk1/2 stimulation may therefore be a key signal for orienting multipolar neurons towards the CP.

FGFRs have been implicated in other developmental cell movements, including migration of mesodermal and tracheal cells in Drosophila (Gisselbrecht et al., 1996; Lebreton and Casanova, 2016), neuroblasts in the mouse olfactory bulb (Zhou et al., 2015) and keratinocytes during repair of epidermal injury (Meyer et al., 2012). A possible role for FGFRs in cortical projection neuron migration has not been reported previously, perhaps because FGFRs are needed for early telencephalon patterning and neurogenesis, and because of functional redundancy (Kang et al., 2009; Paek et al., 2009). Cortical layering was defective in a mouse model expressing dominant-negative FGFR1 during neurogenesis but this could be secondary to the defective radial glia processes (Shin et al., 2004). By inhibiting FGFR signaling in postmitotic neurons, we avoided effects on neurogenesis or radial glia processes. Under these conditions, neurons were delayed in the multipolar migration zone, with randomized orientation, suggesting that FGFRs provide directional information. Conventionally, FGFRs are activated by FGFs and heparan sulfate proteoglycans (Ornitz and Itoh, 2015), so directional information could be provided by an FGF gradient, serving as a chemorepellent or attractant, as in the Drosophila trachea (Lebreton and Casanova, 2016). However, a large number of FGFs are expressed in the developing cortex (Ford-Perriss et al., 2001), making it challenging to identify which, if any, may be involved. It is also possible that NCad activates FGFRs in the absence of FGFs. Reelin could stimulate FGFR-dependent Erk1/2 activity in cultured neurons in the absence of added FGF, suggesting that external FGF may not be needed in vivo. The co-clustering of FGFRs with NCad may be sufficient to activate the receptor independently of FGF, with FGFRs acting as ‘catalytic subunits’ downstream of NCad. A similar mechanism has been suggested for activation by the co-receptor Klotho (Lee et al., 2018).

Our cell culture experiments suggest that NCad stabilizes cell-surface FGFR by inhibiting K27/K29-linked polyubiquitination and lysosomal degradation. Importantly, inhibiting K27-linked polyubiquitination by expression of a mutant ubiquitin rescued the migration of Rap1-inhibited neurons, suggesting that this mechanism also occurs in vivo. The involvement of K27 and K29 is unusual. Polyubiquitin chains assemble through any of seven lysine residues on the ubiquitin molecule, resulting in diverse outcomes for the target protein (Fushman and Wilkinson, 2011). While K11 and K48 polyubiquitination is linked to proteasomal degradation and K63 polyubiquitination to lysosomal degradation, the roles of K6-, K27-, K29-, and of K33-linked ubiquitin chains are less clear (Sadowski et al., 2012). K27 and K29 ubiquitin linkages have been implicated in protein interactions and protein degradation (Chastagner et al., 2006; Ikeda and Kerppola, 2008; Zotti et al., 2011; Fei et al., 2013; Zhou et al., 2013; Birsa et al., 2014; Liu et al., 2014). We found here that both K27 and K29 ubiquitin linkages are necessary for FGFR lysosomal degradation. This may involve mixed linear or mixed branched ubiquitin chains or single K27 and K29 chains attached to different lysine residues on the cytoplasmic tail of FGFRs (Yau and Rape, 2016). The E3 ligase and mechanism of lysosomal targeting remains unclear.

ECad also binds FGFRs but, unlike NCad, does not inhibit FGFR ubiquitination, protect FGFRs from degradation, or regulate multipolar migration in vivo. Using mutated receptors and chimeric proteins, we found that FGFRs bind both ECad and NCad and that binding is necessary but not sufficient to stabilize FGFRs and stimulate multipolar migration. Binding requires the fourth NCad EC domain, but FGFR stabilization and neuronal migration rescue also require the first two NCad domains. Their function is unclear. They may bind to a third partner in the complex that helps NCad inhibit FGFR degradation.

Our results indicated that Reelin does not activate ERK signaling directly but does so by stabilizing FGFR. ERK phosphorylation was delayed, presumably due to the time necessary to accumulate sufficient FGFR. A prolonged Erk1/2 activation might be required to induce a signal as is the case for EGF-induced neuronal differentiation of PC12 cells (Traverse et al., 1994). For instance, Erk1/2 signaling has been linked to transcription of matrix metalloproteinases genes (Westermarck and Kahari, 1999) and some metalloproteinases are essential for the organization of the cerebral cortex (Jorissen et al., 2010). Interestingly, Erk1 and Erk2 double mutant mice exhibit a defect in cortical lamination (Imamura et al., 2010). A cell-autonomous function of Erk1/2 signaling could not be determined because of a failure in maintenance of the radial glia scaffolding. However, our results indicate that Erk1/2 activity is required in migrating neurons during the multipolar phase.

While we were writing this manuscript, FGFR2 was reported to regulate neuronal migration and spine density (Szczurkowska et al., 2018). Defective mice showed impaired core behaviors related to autism spectrum disorders. Interestingly, the Reelin pathway also regulates spine density and has been linked to autism (Niu et al., 2008; Lammert and Howell, 2016). Reelin was also reported to regulate the migration of dopaminergic neurons into the substantia nigra, with induction of bipolar morphology (Vaswani et al., 2019). Additional research will be needed to elucidate the mechanism of FGFRs in Reelin-induced migration and spine density and the link with autism spectrum disorders.

All data generated or analyzed during this study are included in the manuscript and supporting files.

1. 1. Beenken A
   2. Mohammadi M

   (2009) The FGF family: biology, pathophysiology and therapy

   Nature Reviews Drug Discovery 8:235–253.

   https://doi.org/10.1038/nrd2792

   • PubMed
   • Google Scholar
2. 1. Bielas S
   2. Higginbotham H
   3. Koizumi H
   4. Tanaka T
   5. Gleeson JG

   (2004) Cortical neuronal migration mutants suggest separate but intersecting pathways

   Annual Review of Cell and Developmental Biology 20:593–618.

   https://doi.org/10.1146/annurev.cellbio.20.082503.103047

   • PubMed
   • Google Scholar
3. 1. Birsa N
   2. Norkett R
   3. Wauer T
   4. Mevissen TE
   5. Wu HC
   6. Foltynie T
   7. Bhatia K
   8. Hirst WD
   9. Komander D
   10. Plun-Favreau H
   11. Kittler JT

   (2014) Lysine 27 ubiquitination of the mitochondrial transport protein miro is dependent on serine 65 of the parkin ubiquitin ligase

   Journal of Biological Chemistry 289:14569–14582.

   https://doi.org/10.1074/jbc.M114.563031

   • PubMed
   • Google Scholar
4. 1. Boname JM
   2. Thomas M
   3. Stagg HR
   4. Xu P
   5. Peng J
   6. Lehner PJ

   (2010) Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains

   Traffic 11:210–220.

   https://doi.org/10.1111/j.1600-0854.2009.01011.x

   • PubMed
   • Google Scholar
5. 1. Brown WS
   2. Tan L
   3. Smith A
   4. Gray NS
   5. Wendt MK

   (2016) Covalent targeting of fibroblast growth factor receptor inhibits metastatic breast Cancer

   Molecular Cancer Therapeutics 15:2096–2106.

   https://doi.org/10.1158/1535-7163.MCT-16-0136

   • PubMed
   • Google Scholar
6. 1. Chastagner P
   2. Israël A
   3. Brou C

   (2006) Itch/AIP4 mediates deltex degradation through the formation of K29-linked polyubiquitin chains

   EMBO Reports 7:1147–1153.

   https://doi.org/10.1038/sj.embor.7400822

   • PubMed
   • Google Scholar
7. 1. Coci EG
   2. Auhuber A
   3. Langenbach A
   4. Mrasek K
   5. Riedel J
   6. Leenen A
   7. Lücke T
   8. Liehr T

   (2017) Novel unbalanced translocations affecting the long arms of chromosomes 10 and 22 cause complex syndromes with very severe neurodevelopmental delay, speech impairment, autistic behavior, and epilepsy

   Cytogenetic and Genome Research 151:171–178.

   https://doi.org/10.1159/000471501

   • PubMed
   • Google Scholar
8. 1. Cooper JA

   (2014) Molecules and mechanisms that regulate multipolar migration in the intermediate zone

   Frontiers in Cellular Neuroscience 8:386.

   https://doi.org/10.3389/fncel.2014.00386

   • PubMed
   • Google Scholar
9. 1. de Bergeyck V
   2. Nakajima K
   3. Lambert de Rouvroit C
   4. Naerhuyzen B
   5. Goffinet AM
   6. Miyata T
   7. Ogawa M
   8. Mikoshiba K

   (1997) A truncated reelin protein is produced but not secreted in the 'Orleans' reeler mutation (Reln[rl-Orl])

   Molecular Brain Research 50:85–90.

   https://doi.org/10.1016/S0169-328X(97)00166-6

   • PubMed
   • Google Scholar
10. 1. Fei C
    2. Li Z
    3. Li C
    4. Chen Y
    5. Chen Z
    6. He X
    7. Mao L
    8. Wang X
    9. Zeng R
    10. Li L

    (2013) Smurf1-mediated Lys29-linked nonproteolytic polyubiquitination of axin negatively regulates wnt/β-catenin signaling

    Molecular and Cellular Biology 33:4095–4105.

    https://doi.org/10.1128/MCB.00418-13

    • PubMed
    • Google Scholar
11. 1. Ford-Perriss M
    2. Abud H
    3. Murphy M

    (2001) Fibroblast growth factors in the developing central nervous system

    Clinical and Experimental Pharmacology and Physiology 28:493–503.

    https://doi.org/10.1046/j.1440-1681.2001.03477.x

    • PubMed
    • Google Scholar
12. 1. Francis F
    2. Meyer G
    3. Fallet-Bianco C
    4. Moreno S
    5. Kappeler C
    6. Socorro AC
    7. Tuy FP
    8. Beldjord C
    9. Chelly J

    (2006) Human disorders of cortical development: from past to present

    European Journal of Neuroscience 23:877–893.

    https://doi.org/10.1111/j.1460-9568.2006.04649.x

    • PubMed
    • Google Scholar
13. 1. Fushman D
    2. Wilkinson KD

    (2011) Structure and recognition of polyubiquitin chains of different lengths and linkage

    F1000 Biology Reports 3:26.

    https://doi.org/10.3410/B3-26

    • PubMed
    • Google Scholar
14. 1. Gisselbrecht S
    2. Skeath JB
    3. Doe CQ
    4. Michelson AM

    (1996) Heartless encodes a fibroblast growth factor receptor (DFR1/DFGF-R2) involved in the directional migration of early mesodermal cells in the Drosophila embryo

    Genes & Development 10:3003–3017.

    https://doi.org/10.1101/gad.10.23.3003

    • PubMed
    • Google Scholar
15. 1. Haugsten EM
    2. Sørensen V
    3. Brech A
    4. Olsnes S
    5. Wesche J

    (2005) Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors

    Journal of Cell Science 118:3869–3881.

    https://doi.org/10.1242/jcs.02509

    • PubMed
    • Google Scholar
16. 1. Hébert JM

    (2011) FGFs: neurodevelopment's Jack-of-all-Trades - How Do They Do it?

    Frontiers in Neuroscience 5:133.

    https://doi.org/10.3389/fnins.2011.00133

    • PubMed
    • Google Scholar
17. 1. Hong SE
    2. Shugart YY
    3. Huang DT
    4. Shahwan SA
    5. Grant PE
    6. Hourihane JO
    7. Martin ND
    8. Walsh CA

    (2000) Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations

    Nature Genetics 26:93–96.

    https://doi.org/10.1038/79246

    • PubMed
    • Google Scholar
18. 1. Howell BW
    2. Herrick TM
    3. Cooper JA

    (1999) Reelin-induced tyrosine [corrected] phosphorylation of disabled 1 during neuronal positioning

    Genes & Development 13:643–648.

    https://doi.org/10.1101/gad.13.6.643

    • PubMed
    • Google Scholar
19. 1. Hulit J
    2. Suyama K
    3. Chung S
    4. Keren R
    5. Agiostratidou G
    6. Shan W
    7. Dong X
    8. Williams TM
    9. Lisanti MP
    10. Knudsen K
    11. Hazan RB

    (2007) N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation

    Cancer Research 67:3106–3116.

    https://doi.org/10.1158/0008-5472.CAN-06-3401

    • PubMed
    • Google Scholar
20. 1. Ikeda H
    2. Kerppola TK

    (2008) Lysosomal localization of ubiquitinated jun requires multiple determinants in a lysine-27-linked polyubiquitin conjugate

    Molecular Biology of the Cell 19:4588–4601.

    https://doi.org/10.1091/mbc.e08-05-0496

    • PubMed
    • Google Scholar
21. 1. Imamura O
    2. Pagès G
    3. Pouysségur J
    4. Endo S
    5. Takishima K

    (2010) ERK1 and ERK2 are required for radial glial maintenance and cortical lamination

    Genes to Cells 15:1072–1088.

    https://doi.org/10.1111/j.1365-2443.2010.01444.x

    • PubMed
    • Google Scholar
22. 1. Iwata T
    2. Hevner RF

    (2009) Fibroblast growth factor signaling in development of the cerebral cortex

    Development, Growth & Differentiation 51:299–323.

    https://doi.org/10.1111/j.1440-169X.2009.01104.x

    • PubMed
    • Google Scholar
23. 1. Jorissen E
    2. Prox J
    3. Bernreuther C
    4. Weber S
    5. Schwanbeck R
    6. Serneels L
    7. Snellinx A
    8. Craessaerts K
    9. Thathiah A
    10. Tesseur I
    11. Bartsch U
    12. Weskamp G
    13. Blobel CP
    14. Glatzel M
    15. De Strooper B
    16. Saftig P

    (2010) The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex

    Journal of Neuroscience 30:4833–4844.

    https://doi.org/10.1523/JNEUROSCI.5221-09.2010

    • PubMed
    • Google Scholar
24. 1. Jossin Y
    2. Ignatova N
    3. Hiesberger T
    4. Herz J
    5. Lambert de Rouvroit C
    6. Goffinet AM

    (2004) The central fragment of reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development

    Journal of Neuroscience 24:514–521.

    https://doi.org/10.1523/JNEUROSCI.3408-03.2004

    • PubMed
    • Google Scholar
25. 1. Jossin Y
    2. Gui L
    3. Goffinet AM

    (2007) Processing of reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons

    Journal of Neuroscience 27:4243–4252.

    https://doi.org/10.1523/JNEUROSCI.0023-07.2007

    • PubMed
    • Google Scholar
26. 1. Jossin Y

    (2011) Polarization of migrating cortical neurons by Rap1 and N-cadherin: revisiting the model for the reelin signaling pathway

    Small GTPases 2:322–328.

    https://doi.org/10.4161/sgtp.18283

    • PubMed
    • Google Scholar
27. 1. Jossin Y
    2. Cooper JA

    (2011) Reelin, Rap1 and N-cadherin orient the migration of multipolar neurons in the developing neocortex

    Nature Neuroscience 14:697–703.

    https://doi.org/10.1038/nn.2816

    • PubMed
    • Google Scholar
28. 1. Kang W
    2. Wong LC
    3. Shi SH
    4. Hébert JM

    (2009) The transition from radial glial to intermediate progenitor cell is inhibited by FGF signaling during corticogenesis

    Journal of Neuroscience 29:14571–14580.

    https://doi.org/10.1523/JNEUROSCI.3844-09.2009

    • PubMed
    • Google Scholar
29. 1. Katzmann DJ
    2. Odorizzi G
    3. Emr SD

    (2002) Receptor downregulation and multivesicular-body sorting

    Nature Reviews Molecular Cell Biology 3:893–905.

    https://doi.org/10.1038/nrm973

    • PubMed
    • Google Scholar
30. 1. Kawauchi T
    2. Sekine K
    3. Shikanai M
    4. Chihama K
    5. Tomita K
    6. Kubo K
    7. Nakajima K
    8. Nabeshima Y
    9. Hoshino M

    (2010) Rab GTPases-dependent endocytic pathways regulate neuronal migration and maturation through N-cadherin trafficking

    Neuron 67:588–602.

    https://doi.org/10.1016/j.neuron.2010.07.007

    • PubMed
    • Google Scholar
31. 1. Kon E
    2. Cossard A
    3. Jossin Y

    (2017) Neuronal polarity in the embryonic mammalian cerebral cortex

    Frontiers in Cellular Neuroscience 11:163.

    https://doi.org/10.3389/fncel.2017.00163

    • PubMed
    • Google Scholar
32. 1. Lambert de Rouvroit C
    2. Goffinet AM

    (1998) The Reeler mouse as a model of brain development

    Advances in Anatomy, Embryology, and Cell Biology 150:1–106.

    https://doi.org/10.1007/978-3-642-72257-8_1

    • PubMed
    • Google Scholar
33. 1. Lammert DB
    2. Howell BW

    (2016) RELN mutations in autism spectrum disorder

    Frontiers in Cellular Neuroscience 10:84.

    https://doi.org/10.3389/fncel.2016.00084

    • PubMed
    • Google Scholar
34. 1. Lebreton G
    2. Casanova J

    (2016) Ligand-binding and constitutive FGF receptors in single Drosophila tracheal cells: implications for the role of FGF in collective migration

    Developmental Dynamics 245:372–378.

    https://doi.org/10.1002/dvdy.24345

    • PubMed
    • Google Scholar
35. 1. Lee S
    2. Choi J
    3. Mohanty J
    4. Sousa LP
    5. Tome F
    6. Pardon E
    7. Steyaert J
    8. Lemmon MA
    9. Lax I
    10. Schlessinger J

    (2018) Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling

    Nature 553:501–505.

    https://doi.org/10.1038/nature25010

    • PubMed
    • Google Scholar
36. 1. Li YQ
    2. Hii CS
    3. Der CJ
    4. Ferrante A

    (1999) Direct evidence that ERK regulates the production/secretion of interleukin-2 in PHA/PMA-stimulated T lymphocytes

    Immunology 96:524–528.

    https://doi.org/10.1046/j.1365-2567.1999.00724.x

    • PubMed
    • Google Scholar
37. 1. Lim KL
    2. Chew KC
    3. Tan JM
    4. Wang C
    5. Chung KK
    6. Zhang Y
    7. Tanaka Y
    8. Smith W
    9. Engelender S
    10. Ross CA
    11. Dawson VL
    12. Dawson TM

    (2005) Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for lewy body formation

    Journal of Neuroscience 25:2002–2009.

    https://doi.org/10.1523/JNEUROSCI.4474-04.2005

    • PubMed
    • Google Scholar
38. 1. Liu J
    2. Han C
    3. Xie B
    4. Wu Y
    5. Liu S
    6. Chen K
    7. Xia M
    8. Zhang Y
    9. Song L
    10. Li Z
    11. Zhang T
    12. Ma F
    13. Wang Q
    14. Wang J
    15. Deng K
    16. Zhuang Y
    17. Wu X
    18. Yu Y
    19. Xu T
    20. Cao X

    (2014) Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO

    Nature Immunology 15:612–622.

    https://doi.org/10.1038/ni.2898

    • PubMed
    • Google Scholar
39. 1. Mason I

    (2007) Initiation to end point: the multiple roles of fibroblast growth factors in neural development

    Nature Reviews Neuroscience 8:583–596.

    https://doi.org/10.1038/nrn2189

    • PubMed
    • Google Scholar
40. 1. Matsunaga Y
    2. Noda M
    3. Murakawa H
    4. Hayashi K
    5. Nagasaka A
    6. Inoue S
    7. Miyata T
    8. Miura T
    9. Kubo KI
    10. Nakajima K

    (2017) Reelin transiently promotes N-cadherin-dependent neuronal adhesion during mouse cortical development

    PNAS 114:2048–2053.

    https://doi.org/10.1073/pnas.1615215114

    • PubMed
    • Google Scholar
41. 1. Meyer M
    2. Müller AK
    3. Yang J
    4. Moik D
    5. Ponzio G
    6. Ornitz DM
    7. Grose R
    8. Werner S

    (2012) FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin

    Journal of Cell Science 125:5690–5701.

    https://doi.org/10.1242/jcs.108167

    • PubMed
    • Google Scholar
42. 1. Nadarajah B
    2. Alifragis P
    3. Wong RO
    4. Parnavelas JG

    (2003) Neuronal migration in the developing cerebral cortex: observations based on real-time imaging

    Cerebral Cortex 13:607–611.

    https://doi.org/10.1093/cercor/13.6.607

    • PubMed
    • Google Scholar
43. 1. Nadarajah B
    2. Parnavelas JG

    (2002) Modes of neuronal migration in the developing cerebral cortex

    Nature Reviews Neuroscience 3:423–432.

    https://doi.org/10.1038/nrn845

    • PubMed
    • Google Scholar
44. 1. Nakanishi Y
    2. Akiyama N
    3. Tsukaguchi T
    4. Fujii T
    5. Sakata K
    6. Sase H
    7. Isobe T
    8. Morikami K
    9. Shindoh H
    10. Mio T
    11. Ebiike H
    12. Taka N
    13. Aoki Y
    14. Ishii N

    (2014) The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor

    Molecular Cancer Therapeutics 13:2547–2558.

    https://doi.org/10.1158/1535-7163.MCT-14-0248

    • PubMed
    • Google Scholar
45. 1. Nakanishi Y
    2. Mizuno H
    3. Sase H
    4. Fujii T
    5. Sakata K
    6. Akiyama N
    7. Aoki Y
    8. Aoki M
    9. Ishii N

    (2015) ERK signal suppression and sensitivity to CH5183284/Debio 1347, a selective FGFR inhibitor

    Molecular Cancer Therapeutics 14:2831–2839.

    https://doi.org/10.1158/1535-7163.MCT-15-0497

    • PubMed
    • Google Scholar
46. 1. Niu S
    2. Yabut O
    3. D'Arcangelo G

    (2008) The reelin signaling pathway promotes dendritic spine development in hippocampal neurons

    Journal of Neuroscience 28:10339–10348.

    https://doi.org/10.1523/JNEUROSCI.1917-08.2008

    • PubMed
    • Google Scholar
47. 1. Noctor SC
    2. Martínez-Cerdeño V
    3. Ivic L
    4. Kriegstein AR

    (2004) Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases

    Nature Neuroscience 7:136–144.

    https://doi.org/10.1038/nn1172

    • PubMed
    • Google Scholar
48. 1. O'Donovan MC
    2. Norton N
    3. Williams H
    4. Peirce T
    5. Moskvina V
    6. Nikolov I
    7. Hamshere M
    8. Carroll L
    9. Georgieva L
    10. Dwyer S
    11. Holmans P
    12. Marchini JL
    13. Spencer CC
    14. Howie B
    15. Leung HT
    16. Giegling I
    17. Hartmann AM
    18. Möller HJ
    19. Morris DW
    20. Shi Y
    21. Feng G
    22. Hoffmann P
    23. Propping P
    24. Vasilescu C
    25. Maier W
    26. Rietschel M
    27. Zammit S
    28. Schumacher J
    29. Quinn EM
    30. Schulze TG
    31. Iwata N
    32. Ikeda M
    33. Darvasi A
    34. Shifman S
    35. He L
    36. Duan J
    37. Sanders AR
    38. Levinson DF
    39. Adolfsson R
    40. Osby U
    41. Terenius L
    42. Jönsson EG
    43. Cichon S
    44. Nöthen MM
    45. Gill M
    46. Corvin AP
    47. Rujescu D
    48. Gejman PV
    49. Kirov G
    50. Craddock N
    51. Williams NM
    52. Owen MJ
    53. Molecular Genetics of Schizophrenia Collaboration

    (2009) Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2

    Molecular Psychiatry 14:30–36.

    https://doi.org/10.1038/mp.2008.108

    • PubMed
    • Google Scholar
49. 1. Okazaki T
    2. Saito Y
    3. Ueda R
    4. Awashima T
    5. Nishimura Y
    6. Yuasa I
    7. Shinohara Y
    8. Adachi K
    9. Sasaki M
    10. Nanba E
    11. Maegaki Y

    (2017) Epileptic phenotype of FGFR3-related bilateral medial temporal lobe dysgenesis

    Brain and Development 39:67–71.

    https://doi.org/10.1016/j.braindev.2016.07.004

    • PubMed
    • Google Scholar
50. 1. Ornitz DM
    2. Itoh N

    (2015) The fibroblast growth factor signaling pathway

    Wiley Interdisciplinary Reviews: Developmental Biology 4:215–266.

    https://doi.org/10.1002/wdev.176

    • PubMed
    • Google Scholar
51. 1. Paek H
    2. Gutin G
    3. Hébert JM

    (2009) FGF signaling is strictly required to maintain early telencephalic precursor cell survival

    Development 136:2457–2465.

    https://doi.org/10.1242/dev.032656

    • PubMed
    • Google Scholar
52. 1. Parnavelas JG

    (2000) The origin and migration of cortical neurones: new vistas

    Trends in Neurosciences 23:126–131.

    https://doi.org/10.1016/S0166-2236(00)01553-8

    • PubMed
    • Google Scholar
53. 1. Pertz O
    2. Bozic D
    3. Koch AW
    4. Fauser C
    5. Brancaccio A
    6. Engel J

    (1999) A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation

    The EMBO Journal 18:1738–1747.

    https://doi.org/10.1093/emboj/18.7.1738

    • PubMed
    • Google Scholar
54. 1. Piper RC
    2. Dikic I
    3. Lukacs GL

    (2014) Ubiquitin-dependent sorting in endocytosis

    Cold Spring Harbor Perspectives in Biology 6:a016808.

    https://doi.org/10.1101/cshperspect.a016808

    • PubMed
    • Google Scholar
55. 1. Qian X
    2. Anzovino A
    3. Kim S
    4. Suyama K
    5. Yao J
    6. Hulit J
    7. Agiostratidou G
    8. Chandiramani N
    9. McDaid HM
    10. Nagi C
    11. Cohen HW
    12. Phillips GR
    13. Norton L
    14. Hazan RB

    (2014) N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties

    Oncogene 33:3411–3421.

    https://doi.org/10.1038/onc.2013.310

    • Google Scholar
56. 1. Rash BG
    2. Grove EA

    (2006) Area and layer patterning in the developing cerebral cortex

    Current Opinion in Neurobiology 16:25–34.

    https://doi.org/10.1016/j.conb.2006.01.004

    • PubMed
    • Google Scholar
57. 1. Romero DM
    2. Bahi-Buisson N
    3. Francis F

    (2018) Genetics and mechanisms leading to human cortical malformations

    Seminars in Cell & Developmental Biology 76:33–75.

    https://doi.org/10.1016/j.semcdb.2017.09.031

    • PubMed
    • Google Scholar
58. 1. Sadowski M
    2. Suryadinata R
    3. Tan AR
    4. Roesley SN
    5. Sarcevic B

    (2012) Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes

    IUBMB Life 64:136–142.

    https://doi.org/10.1002/iub.589

    • PubMed
    • Google Scholar
59. 1. Sanchez-Heras E
    2. Howell FV
    3. Williams G
    4. Doherty P

    (2006) The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule

    Journal of Biological Chemistry 281:35208–35216.

    https://doi.org/10.1074/jbc.M608655200

    • PubMed
    • Google Scholar
60. 1. Schaller T
    2. Pollpeter D
    3. Apolonia L
    4. Goujon C
    5. Malim MH

    (2014) Nuclear import of SAMHD1 is mediated by a classical karyopherin α/β1 dependent pathway and confers sensitivity to VpxMAC induced ubiquitination and proteasomal degradation

    Retrovirology 11:29.

    https://doi.org/10.1186/1742-4690-11-29

    • PubMed
    • Google Scholar
61. 1. Shin DM
    2. Korada S
    3. Raballo R
    4. Shashikant CS
    5. Simeone A
    6. Taylor JR
    7. Vaccarino F

    (2004) Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice

    Journal of Neuroscience 24:2247–2258.

    https://doi.org/10.1523/JNEUROSCI.5285-03.2004

    • PubMed
    • Google Scholar
62. 1. Suyama K
    2. Shapiro I
    3. Guttman M
    4. Hazan RB

    (2002) A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor

    Cancer Cell 2:301–314.

    https://doi.org/10.1016/S1535-6108(02)00150-2

    • PubMed
    • Google Scholar
63. 1. Szczurkowska J
    2. Pischedda F
    3. Pinto B
    4. Managò F
    5. Haas CA
    6. Summa M
    7. Bertorelli R
    8. Papaleo F
    9. Schäfer MK
    10. Piccoli G
    11. Cancedda L

    (2018) NEGR1 and FGFR2 cooperatively regulate cortical development and core behaviours related to autism disorders in mice

    Brain 50:2772–2794.

    https://doi.org/10.1093/brain/awy190

    • Google Scholar
64. 1. Tabata H
    2. Nakajima K

    (2001) Efficient in utero gene transfer system to the developing mouse brain using electroporation: visualization of neuronal migration in the developing cortex

    Neuroscience 103:865–872.

    https://doi.org/10.1016/S0306-4522(01)00016-1

    • PubMed
    • Google Scholar
65. 1. Tabata H
    2. Nakajima K

    (2003) Multipolar migration: the third mode of radial neuronal migration in the developing cerebral cortex

    The Journal of Neuroscience 23:9996–10001.

    https://doi.org/10.1523/JNEUROSCI.23-31-09996.2003

    • PubMed
    • Google Scholar
66. 1. Takahashi T
    2. Goto T
    3. Miyama S
    4. Nowakowski RS
    5. Caviness VS

    (1999) Sequence of neuron origin and neocortical laminar fate: relation to cell cycle of origin in the developing murine cerebral wall

    The Journal of Neuroscience 19:10357–10371.

    https://doi.org/10.1523/JNEUROSCI.19-23-10357.1999

    • PubMed
    • Google Scholar
67. 1. Tamura K
    2. Shan WS
    3. Hendrickson WA
    4. Colman DR
    5. Shapiro L

    (1998) Structure-function analysis of cell adhesion by neural (N-) cadherin

    Neuron 20:1153–1163.

    https://doi.org/10.1016/S0896-6273(00)80496-1

    • PubMed
    • Google Scholar
68. 1. Tan AP
    2. Mankad K

    (2018) A unique case of lissencephaly with crouzon syndrome heterozygous for FGFR2 mutation

    Child's Nervous System 34:23–25.

    https://doi.org/10.1007/s00381-017-3646-0

    • PubMed
    • Google Scholar
69. 1. Terwisscha van Scheltinga AF
    2. Bakker SC
    3. Kahn RS
    4. Kas MJ

    (2013) Fibroblast growth factors in neurodevelopment and psychopathology

    The Neuroscientist 19:479–494.

    https://doi.org/10.1177/1073858412472399

    • PubMed
    • Google Scholar
70. 1. Traverse S
    2. Seedorf K
    3. Paterson H
    4. Marshall CJ
    5. Cohen P
    6. Ullrich A

    (1994) EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor

    Current Biology 4:694–701.

    https://doi.org/10.1016/S0960-9822(00)00154-8

    • PubMed
    • Google Scholar
71. 1. Uchida T
    2. Baba A
    3. Pérez-Martínez FJ
    4. Hibi T
    5. Miyata T
    6. Luque JM
    7. Nakajima K
    8. Hattori M

    (2009) Downregulation of functional reelin receptors in projection neurons implies that primary reelin action occurs at early/premigratory stages

    Journal of Neuroscience 29:10653–10662.

    https://doi.org/10.1523/JNEUROSCI.0345-09.2009

    • PubMed
    • Google Scholar
72. 1. Ueno H
    2. Gunn M
    3. Dell K
    4. Tseng A
    5. Williams L

    (1992)

    A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor

    The Journal of Biological Chemistry 267:1470–1476.

    • PubMed
    • Google Scholar
73. 1. Vaswani AR
    2. Weykopf B
    3. Hagemann C
    4. Fried HU
    5. Brüstle O
    6. Blaess S

    (2019) Correct setup of the substantia nigra requires Reelin-mediated fast, laterally-directed migration of dopaminergic neurons

    eLife 8:e41623.

    https://doi.org/10.7554/eLife.41623

    • PubMed
    • Google Scholar
74. 1. Watts RG
    2. Huang C
    3. Young MR
    4. Li JJ
    5. Dong Z
    6. Pennie WD
    7. Colburn NH

    (1998) Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation

    Oncogene 17:3493–3498.

    https://doi.org/10.1038/sj.onc.1202259

    • PubMed
    • Google Scholar
75. 1. Wentz E
    2. Vujic M
    3. Kärrstedt E-L
    4. Erlandsson A
    5. Gillberg C

    (2014) A case report of two male siblings with autism and duplication of Xq13–q21, a region including three genes predisposing for autism

    European Child & Adolescent Psychiatry 23:329–336.

    https://doi.org/10.1007/s00787-013-0455-1

    • Google Scholar
76. 1. Wesche J
    2. Haglund K
    3. Haugsten EM

    (2011) Fibroblast growth factors and their receptors in Cancer

    Biochemical Journal 437:199–213.

    https://doi.org/10.1042/BJ20101603

    • PubMed
    • Google Scholar
77. 1. Westermarck J
    2. Kahari VM

    (1999) Regulation of matrix metalloproteinase expression in tumor invasion

    The FASEB Journal 13:781–792.

    https://doi.org/10.1096/fasebj.13.8.781

    • Google Scholar
78. 1. Williams EJ
    2. Furness J
    3. Walsh FS
    4. Doherty P

    (1994) Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin

    Neuron 13:583–594.

    https://doi.org/10.1016/0896-6273(94)90027-2

    • PubMed
    • Google Scholar
79. 1. Williams EJ
    2. Williams G
    3. Howell FV
    4. Skaper SD
    5. Walsh FS
    6. Doherty P

    (2001) Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth

    Journal of Biological Chemistry 276:43879–43886.

    https://doi.org/10.1074/jbc.M105876200

    • PubMed
    • Google Scholar
80. 1. Yau R
    2. Rape M

    (2016) The increasing complexity of the ubiquitin code

    Nature Cell Biology 18:579–586.

    https://doi.org/10.1038/ncb3358

    • PubMed
    • Google Scholar
81. 1. Zampieri CA
    2. Fortin J-F
    3. Nolan GP
    4. Nabel GJ

    (2007) The ERK Mitogen-Activated protein kinase pathway contributes to ebola virus Glycoprotein-Induced cytotoxicity

    Journal of Virology 81:1230–1240.

    https://doi.org/10.1128/JVI.01586-06

    • Google Scholar
82. 1. Zhou HL
    2. Geng C
    3. Luo G
    4. Lou H

    (2013) The p97-UBXD8 complex destabilizes mRNA by promoting release of ubiquitinated HuR from mRNP

    Genes & Development 27:1046–1058.

    https://doi.org/10.1101/gad.215681.113

    • PubMed
    • Google Scholar
83. 1. Zhou Y
    2. Oudin MJ
    3. Gajendra S
    4. Sonego M
    5. Falenta K
    6. Williams G
    7. Lalli G
    8. Doherty P

    (2015) Regional effects of endocannabinoid, BDNF and FGF receptor signalling on neuroblast motility and guidance along the rostral migratory stream

    Molecular and Cellular Neuroscience 64:32–43.

    https://doi.org/10.1016/j.mcn.2014.12.001

    • PubMed
    • Google Scholar
84. 1. Zotti T
    2. Uva A
    3. Ferravante A
    4. Vessichelli M
    5. Scudiero I
    6. Ceccarelli M
    7. Vito P
    8. Stilo R

    (2011) TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation

    Journal of Biological Chemistry 286:22924–22933.

    https://doi.org/10.1074/jbc.M110.215426

    • PubMed
    • Google Scholar

[Editors’ note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.]

Thank you for submitting your work entitled "FGFR ubiquitination and degradation controls neuronal migration in vivo" for consideration by eLife. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Ivan Dikic as the Reviewing and Senior Editor. The following individual involved in review of your submission have agreed to reveal their identity: Mary E Hatten (Reviewer #2).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in eLife.

Summary:

The manuscript studies the role of FGF receptors in the migration of cortical projection neurons. The authors show that interaction of FGFR with N-Cadherin, CDH2, seems to protect FGFR from ubiquitination and subsequent degradation by lysosome. This leads to sustained FGFR levels and increased Erk1/2 downstream signaling which the authors propose regulates neuronal migration. Reelin seems important for FGFR-mediated Erk1/2 signaling, presumably by stabilizing and/or recruiting N-Cadherin to the plasma membrane.

While a number of interesting observations are presented, none directly assays FGFR function in cortical neuron migration. Rather, the data appear to show that disruption of FGFR and/or FGFR signaling stalls neuronal development at the multipolar stage, thereby preventing further differentiation and/or migration to form the neuronal layers. The experimental design and performance were nice, but the experiments are carried out mostly in HEK293 cells, not on developing cortical neurons. In addition, from the currently presented data it is difficult to see a coherent model for how the FGFRs actually function in locomotion (or a polarity defect at the multipolar stage). In total, the authors failed to demonstrate a direct function for FGFRs in migration in neurons.

The essential revisions to improve this work include a number of issues indicated in the reviews. In particular we feel that providing live-imaging data to resolve whether and to which extent FGFR signaling is required for migration versus polarization/differentiation is needed. In addition the authors need to repeat the biochemistry/pathways experiments in primary cortical cells and also draw a more coherent model of their functional relevance in vivo. Taken together, substantial amount of additional data is required in order to reach the high standard of eLife. If the authors wish to submit the work again to eLife following their revisions fulfilling the raised points at a later time the manuscript will be considered as a new submission.

Reviewer #1:

Kon and colleagues address important questions in cortical development and convincingly demonstrate an essential function for FGFR signaling in radial projection neuron migration. By using in utero electroporation (for gene knockdown) and structure function analysis, the authors elucidate mechanistic details. They show that interaction of FGFR with N-Cadherin, CDH2, seems to protect FGFR from ubiquitination and subsequent degradation by lysosome. This leads to sustained FGFR levels and increased Erk1/2 downstream signaling which regulates neuronal migration. Interestingly, Reelin is an important upstream regulatory component and seems important for FGFR-mediated Erk1/2 signaling, presumably by stabilizing and/or recruiting N-Cadherin to the plasma membrane.

Overall the manuscript by Kon et al. investigates timely aspects in cortical development. The manuscript is well written and the findings illustrated nicely. Some of the claims could be further substantiated by addressing the following points:

1) The authors propose that FGFR signaling is important for polarization and/or orientation of neurons in the MMZ. However the actual data supporting this claim directly is a bit slim. In Figure 1B the authors stain and assay for the location of Golgi but it is very difficult to appreciate the defect in orientation in relation to the cortical plate. Perhaps more important would be to document and quantify the disoriented direction of multipolar migration by life-imaging. This piece of data will be critical since it will provide mechanistic insight at the cellular level and further contribute to the conceptual advance of the study.

2) Figure 5B could be improved by showing the real microscopic images that relate to the quantification chart.

3) The Discussion ends a bit abruptly and a conclusive paragraph is needed. The authors should also discuss their findings in a somewhat broader context. They should elaborate how their findings extend and complement the current model of FGFR function in neuronal migration in vivo, which was recently published by the Cancedda lab.

Reviewer #2:

The manuscript by Cooper and colleagues "FGFR ubiquitination and degradation controls neuronal migration in vivo" presents a series of experiments on cortical development the stated purpose of which is to investigate the role of FGF receptors in the migration of cortical projection neurons. While a number of interesting observations are presented, none directly assays FGFR function in cortical neuron migration and the various pathways investigated do not inform a coherent model of how FGFRs would directly function in neuronal locomotion. Rather, the data appear to show that disruption of FGFR function stalls neuronal development at the multipolar stage, thereby preventing further differentiation and/or migration to form the neuronal layers. Also, while the pathways that impact FGFR dependent ERK1/2 phosphorylation and degradation are interesting vis a vis downstream signaling pathways, and the experiments are nicely done, the experiments are carried out in HEK293 cells, not on developing cortical neurons. The paper fails to demonstrate a direct function for FGFRs in migration.

Specific issues include the following:

1) Expression of a dominant negative form of the receptor is not as clean as a conditional genetic experiment in cortical projection neurons. As is true with many electroporation approaches, the identity of the neuronal populations that are affected are not specified.

2) There is no direct evidence that the FGFR family members act redundantly during the transition from the multipolar to bipolar stage and migration into the cortical plate. Can the dominant negative FGFR dimerize with receptors other than FGFR family members or N-Cad? Such interactions could contribute to the phenotypes observed.

3) Does NCad-dEC4 bind to receptors other than FGFRs?

4) Assays to identify binding partners, e.g. IP/mass spec experiments using lysates from primary cortical neurons expressing the dominant negative FGFR and NCad-dEC4 proteins, would be more informative.

5) While the HEK293T cells are a great starting point for the biochemistry, it is critical to perform the protein interaction and expression assays using purified cortical neurons or at least cultured primary cortical neurons. The fact that these changes, or lack of changes in some cases, occur in HEK293T cells does not guarantee that this is the case in post-mitotic cortical neurons.

6) There appears to be a disconnect between the Rap1/CDH2/FGFR and Reelin/FGFR/ERK1 and 2 signaling pathways in this manuscript that are bridged by the following sentence and the authors' previous paper "The Rap1-dependent upregulation of NCad is triggered by Reelin, an extracellular ligand present in the MMZ (Jossin and Cooper, 2011)". This needs to be more clearly stated.

7) Why is there no control image for Figure 1B to show the Golgi orientation of control cells?

8) Figure 2A and 3D: Why is FGFR expression not visible in all lanes on the WB when the protein is overexpressed? If it is a matter of exposure time, it would be preferable to use longer exposures in order to see bands in all lanes that indicate FGFR expression. It would also be helpful to see loading controls like in Figure 3D.

9) Figure 3A and 3B: In contrast to Figure 2C, there is no increase in FGFR1-Myc when co-expressed with NCad-HA. If the DNA concentration is adjusted as noted in the legend, it would still be expected that the NCad-HA and NCad-W161A-HA lanes show similar levels of FGFR1-Myc, which they do not. FGFR1 appears even lower when co-expressed with NCad-HA. On the other hand, NCad-dEC4, which is proposed to not interact with FGFR1, seems to increase FGFR1 expression. I would suggest to show blots with consistent data, or remove those claims in the text.

10) The authors state that NCad-dEC4 does not interact with FGFR1 and is unable to rescue migration defects in Rap1GAP cells, which indicates that NCad interacts with FGFR1 through its EC4 domain. However, the data in Figure 5 shows that NCad increases FGFR1 expression and promotes neuronal migration through its EC1-2 domains. The same figure also shows that the EC4 domain-containing chimeric E/NCad does not increase FGFR or promote migration. This is confusing. If NCad does interact with FGFR1 via EC4 and promotes migration via EC1-2, it would suggest that homophilic binding of NCad or heterophilic binding to other proteins, in addition to heterophilic NCad:FGFR binding, plays a role in migration. Nevertheless, the authors present data indicating that homophilic NCad interactions do not have a role migration. These data need clarification.

11) Were the ERK1/2 constructs expressed in cortical neurons selectively expressed in post-mitotic cells?

12) The Discussion ends rather abruptly.

[Editors’ note: what now follows is the decision letter after the authors submitted for further consideration.]

Thank you for sending your article entitled "FGFR ubiquitination and degradation control neuronal migration in vivo" for peer review at eLife. Your article is being evaluated by two peer reviewers, and the evaluation is being overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor.

The reviewers are somewhat split regarding the revision of this manuscript. In particular, reviewer 2 raises important issues regarding the specificity of the FGFR loss-of-function experiments and well as conclusions drawn from the imaging. In particular, it would be important to include a more specific conditional knock-down and better imaging including live imaging.

Given the list of essential revisions, including new experiments, the editors and reviewers invite you to respond within the next two weeks with an action plan and timetable for the completion of the additional work. We plan to share your responses with the reviewers and then issue a binding recommendation. The full reviews are listed below.

Reviewer #1:

Kon and colleagues address important questions in cortical development and convincingly demonstrate an essential function for FGFR signaling in radial projection neuron migration. More specifically the authors show that FGFR-mediated signaling regulates multipolar migration and the switch to bipolar morphology. By using in utero electroporation (for gene knockdown) and structure function analysis, the authors elucidated mechanistic details. They show that interaction of FGFR with N-Cadherin, CDH2, seems to protect FGFR from ubiquitination and subsequent degradation by lysosome. This leads to sustained FGFR levels and increased Erk1/2 downstream signaling. Interestingly, Reelin is an important upstream regulatory component and seems important for FGFR-mediated Erk1/2 signaling, presumably by stabilizing and/or recruiting N-Cadherin to the plasma membrane. The study by Kon et al. investigates timely aspects in cortical development.

This version of the manuscript improved, is very well written and the findings illustrated nicely. The authors added new and important data which greatly support and strengthen the main conclusions of the manuscript. The authors made an effort to clarify the writing in general and now explicitly state that FGFR signaling controls multipolar migration and subsequent switch to bipolar morphology. Given the convincing data and additional experimental evidence the current data set supports the main conclusions of the manuscript very well, even without direct live-imaging data. Overall this study is likely to be of great interest to the broader neuroscience community.

Reviewer #2:

Kon et al. revised their manuscript ʺFGFR ubiquitination and degradation controls neuronal migration in vivoʺ to reflect their observation that cortical neurons appear to stall at the multipolar stage when FGFR signaling is perturbed by transgenic expression of DN FGFR. They have done a nice job of streamlining the biochemical and in utero electroporation epistasis experiments, and performing more of the biochemical experiments in cultured cortical neurons as requested, to work out the signaling mechanism involved. While the manuscript overall has improved, there are several issues that I feel do not make it suitable for publication in eLife at this time and may be more suitable for a more specialized journal.

First, I still worry that expression of a DN FGFR, as opposed to conditional genetic loss of function experiments, may have some off-target effects. In addition, the finding by Szczurkowska et al., 2018, that FGFR2 regulates neuronal migration and spine density suggests that the FGFRs may not act redundantly.

Second, I do not agree that the terminology "multipolar migration" is justified without more detailed analysis of the cellular mechanism involved. Better high magnification/resolution images of cell morphology at this stage, combined with live imaging, would be required to determine why and how these cells are stalling.

[Editors’ note: the author responses to the first round of peer review follow.]

Summary:

The manuscript studies the role of FGF receptors in the migration of cortical projection neurons. The authors show that interaction of FGFR with N-Cadherin, CDH2, seems to protect FGFR from ubiquitination and subsequent degradation by lysosome. This leads to sustained FGFR levels and increased Erk1/2 downstream signaling which the authors propose regulates neuronal migration. Reelin seems important for FGFR-mediated Erk1/2 signaling, presumably by stabilizing and/or recruiting N-Cadherin to the plasma membrane.

While a number of interesting observations are presented, none directly assays FGFR function in cortical neuron migration. Rather, the data appear to show that disruption of FGFR and/or FGFR signaling stalls neuronal development at the multipolar stage, thereby preventing further differentiation and/or migration to form the neuronal layers. The experimental design and performance were nice, but the experiments are carried out mostly in HEK293 cells, not on developing cortical neurons. In addition, from the currently presented data it is difficult to see a coherent model for how the FGFRs actually function in locomotion (or a polarity defect at the multipolar stage). In total, the authors failed to demonstrate a direct function for FGFRs in migration in neurons.

The essential revisions to improve this work include a number of issues indicated in the reviews. In particular we feel that providing live-imaging data to resolve whether and to which extent FGFR signaling is required for migration versus polarization/differentiation is needed. In addition the authors need to repeat the biochemistry/pathways experiments in primary cortical cells and also draw a more coherent model of their functional relevance in vivo. Taken together, substantial amount of additional data is required in order to reach the high standard of eLife. If the authors wish to submit the work again to eLife following their revisions fulfilling the raised points at a later time the manuscript will be considered as a new submission.

We thank the editor and reviewers for the summary. In response we have performed additional experiments and rewritten the text to improve logical flow. In summary:

1) We agree that disrupting FGFR signaling stalls or delays neurons at the multipolar stage. While our new data show that the phenotype is not due to a defect in differentiation, the evidence points to a failure before multipolar neurons become bipolar. This is the same phenotype as we described before when we inhibited Reelin receptors, Rap1 or N‐cadherin (Ncad) (Jossin and Cooper, 2011). In those experiments, we tracked neurons in slice cultures and found that migration speed was normal but the migration paths were more erratic, with more neurons moving down or sideways compared with controls. While we now lack the facilities to image neurons in slice culture, we show that blocking FGFR signaling has a similar effect as blocking Rap1 or NCad on neuron morphology and orientation near the top of the multipolar zone. Moreover, FGFR expression rescues multipolar neurons with inactive Rap1. Since Rap1 and NCad‐dependent FGFR activation by Reelin stimulates Erk, and since inhibiting Erk also delays neurons at the multipolar stage, we suspect that FGFRs may be needed for Erk‐dependent signals activated by Reelin in multipolar neurons. These signals might include expression of genes required for polarization, orientation or migration, but it would likely require single cell RNA‐Seq to identify a distinct differentiation state. To avoid misleading the reader as to the precise nature of the migration defect, we have now replaced “defect in neuronal migration” with “defect in multipolar migration”.

2) The original paper presented in vivo results, from in utero electroporation, showing:

a) Dominant‐negative FGFRs disturb the migration of neurons with multipolar morphology and impair their orientation towards the cortical plate.

b) Wildtype FGFR expression rescues migration of neurons with inhibited Rap1.

c) Ncad‐mediated cell‐cell adhesion is not needed for neuron migration in vivo.

d) NCad that cannot bind FGFRs does not rescue neurons with inhibited Rap1.

e) Over‐expressing ubiquitin K27R inhibits FGFR downregulation and rescues Rap1inhibited neurons.

f) While both ECad and NCad bind FGFRs, ECad does not prevent FGFR degradation and does not rescue multipolar migration in vivo unless it carries the NCad EC1‐2 region.

g) Dominant‐negative but not wildtype Erk1 or Erk2 inhibits multipolar neuron migration in vivo.

These in vivo experiments were complemented by experiments with cultured embryonic cortical neurons showing that long‐term stimulation with Reelin increases endogenous FGFR1 expression and activates Erk, dependent on FGFR kinase activity, and that endogenous FGFRs are degraded by the lysosome pathway. Transfected HEK293 cells were used for biochemical experiments to validate the NCad mutants used, to confirm that NCad binds to and inhibits ubiquitination and degradation of FGFRs, and to identify the ubiquitin linkage in polyubiquitinated FGFR. In restructuring the paper, we have moved many of the HEK293 experiments to supplementary figures, to focus attention on the in vivo and neuron culture experiments. We also provide the following new data:

a) Neuron proliferation, apoptosis, and differentiation state, as determined with

Sox2, Tbr2 and Satb2, are unaffected when FGFRs are inhibited in vivo (new Figure 2A).

b) Inhibition of FGFRs in vivo affects the morphological switch from multipolar to bipolar (new Figure 2C).

c) Transfected FGFR levels decrease when Rap1 is inhibited in utero (new Figure 3B).

d) Endogenous FGFR levels increase when NCad is expressed in primary neurons (new Figure 3C).

e) Increased FGFR protein levels and activation of Erk in Reelin‐stimulated neurons requires Rap1 and NCad (new Figure 8D).

Other figures have been updated with improved data. We hope that the reviewers will understand that repeating all the biochemical experiments in neurons would be very time consuming and will excuse the remaining HEK293 experiments.

Reviewer #1:

[…] Overall the manuscript by Kon et al. investigates timely aspects in cortical development. The manuscript is well written and the findings illustrated nicely. Some of the claims could be further substantiated by addressing the following points:

1) The authors propose that FGFR signaling is important for polarization and/or orientation of neurons in the MMZ. However the actual data supporting this claim directly is a bit slim. In Figure 1B the authors stain and assay for the location of Golgi but it is very difficult to appreciate the defect in orientation in relation to the cortical plate. Perhaps more important would be to document and quantify the disoriented direction of multipolar migration by life-imaging. This piece of data will be critical since it will provide mechanistic insight at the cellular level and further contribute to the conceptual advance of the study.

We agree that live imaging would be a great addition to this study. Unfortunately, we no longer have the facilities for live imaging. Nevertheless, we improved the quality of the images provided in the new Figure 2B so the reader could better appreciate the phenotype. We went further in the description of the phenotype by showing a delay in the morphological transition from multipolar to bipolar cell (new Figure 2C). While the phenotype is very similar to that caused by inhibiting Rap1 or NCad (Jossin and Cooper, 2011),, we have bolstered the evidence that FGFR function is linked to the Reelin/Rap1/NCad pathway by adding new data: Reelin increases FGFR signaling in primary cortical neuron cultures, in an NCad‐dependent manner; Rap1 inhibition in vivo decreases FGFR protein level in multipolar neurons; NCad over‐expression in neurons increases FGFR protein level; FGFR inhibition does not alter cell fate, proliferation or survival in vivo.

2) Figure 5B could be improved by showing the real microscopic images that relate to the quantification chart.

We thank the reviewer for their comments. The requested pictures have been added (new Figure 6B).

3) The Discussion ends a bit abruptly and a conclusive paragraph is needed. The authors should also discuss their findings in a somewhat broader context. They should elaborate how their findings extend and complement the current model of FGFR function in neuronal migration in vivo, which was recently published by the Cancedda lab.

The interesting paper from Szczurkowska et al. shows that inhibiting FGFR expression impairs migration of late‐born neurons and decreases spine density after neurons mature. The first result is expected in light of our observation of a defect in multipolar migration. The second result also suggests parallels with Reelin signaling, because Reelin also increases spine density. Szczurkowska et al. have the added twist that another cell adhesion molecule, NEGR1 also inhibits FGFR degradation. This suggests that at least two pathways – Reelin/Rap1/NCad and NEGR1 – stabilize FGFRs and increase signaling. We have added a concluding paragraph commenting on this new paper.

Reviewer #2:

The manuscript by Cooper and colleagues "FGFR ubiquitination and degradation controls neuronal migration in vivo" presents a series of experiments on cortical development the stated purpose of which is to investigate the role of FGF receptors in the migration of cortical projection neurons. While a number of interesting observations are presented, none directly assays FGFR function in cortical neuron migration and the various pathways investigated do not inform a coherent model of how FGFRs would directly function in neuronal locomotion. Rather, the data appear to show that disruption of FGFR function stalls neuronal development at the multipolar stage, thereby preventing further differentiation and/or migration to form the neuronal layers.

We never stated that FGFRs were involved in neuronal locomotion but may have implied it by our use of the generic term “neuronal migration”. We use now the more precise term “multipolar migration”. Cortical projection neurons go through two types of migration: multipolar migration and bipolar migration (or locomotion). Our results show that FGFRs are important for the multipolar migration that occurs before locomotion. The results provided here suggest that the Reelin/Rap1/Ncad pathway regulates FGFRs to control multipolar migration and our previous studies on Rap1‐inhibited neurons revealed no alteration in locomotion. We are sorry that it was confusing and we have made changes in the text to clarify this issue. Please see general point 1 above.

We have now added immunostaining results to show that neuronal differentiation, proliferation and survival are not affected in vivo (Figure 2A). However, we cannot exclude that the neurons are in a subtly different stage of differentiation that may be revealed by detailed gene expression analysis.

Also, while the pathways that impact FGFR dependent ERK1/2 phosphorylation and degradation are interesting vis a vis downstream signaling pathways, and the experiments are nicely done, the experiments are carried out in HEK293 cells, not on developing cortical neurons. The paper fails to demonstrate a direct function for FGFRs in migration.

In the previous version of the paper, we made use of cultured embryonic cortical neurons to show that long‐term stimulation with Reelin increases endogenous FGFR1 expression and activates Erk, dependent on FGFR kinase activity, and that endogenous FGFRs undergo lysosomal, not proteasomal, degradation. In the re‐submission, we have added new data showing that NCad over‐expression in cortical neurons increases endogenous FGFR1 protein level (new Figure 3C), that activation of Erk in Reelin simulated cortical neurons requires Rap1 and NCad (new Figure 8D), and that FGFR levels decrease when Rap1 is inhibited in utero (Figure 3B). HEK293 cells, which share features with neurons (Shaw et al. 2002, PMID 11967234), were used to validate the NCad mutants used, to confirm that NCad binds to and inhibits ubiquitination and degradation of FGFRs, and to identify the K27/29 ubiquitin linkage in polyubiquitinated FGFR. Such an extensive series of transfection experiments would be challenging in primary neurons. We feel that the preponderance of evidence supports the model depicted in Figure 9B, but there are gaps in our knowledge that we discuss frankly in the text.

Specific issues include the following:

1) Expression of a dominant negative form of the receptor is not as clean as a conditional genetic experiment in cortical projection neurons.

It is true that the use of dominant‐negative forms has disadvantages but conditional knockout with post‐mitotic neuronal drivers such as Dcx‐Cre may not be effective if there is perdurance of FGFR mRNA or protein. In addition, FGFR1‐3 have overlapping activators and downstream effectors. By using the NeuroD promoter to inhibit the whole family of FGFRs we can rapidly inhibit FGFR signaling in migrating neurons without disrupting neurogenesis. There were no effects of electroporating the full-length FGFRs under similar conditions, suggesting that FGFR cytoplasmic domain functions are required for normal migration.

As is true with many electroporation approaches, the identity of the neuronal populations that are affected are not specified.

We agree with this limitation. The neuronal populations affected are those derived from apical progenitors in the neocortical VZ at the time of electroporation and their progeny. This includes postmitotic neurons and basal progenitors. However, the number of Tbr2 positive basal progenitors in the electroporated area was not affected by DN FGFRs (new Figure 2A). In addition, there was no change in the number of Satb2 positive neurons destined for the upper CP, or in Sox2 positive apical neural stem cells. Cell proliferation and cell survival were also unaffected (new Figure 2A).

2) There is no direct evidence that the FGFR family members act redundantly during the transition from the multipolar to bipolar stage and migration into the cortical plate.

FGFR1‐3 are all expressed in the developing neocortex. Single mutants have subtle defects and the triple mutant has no telencephalon, precluding investigation of neuron migration (Paek et al., 2009; Iwata and Hevner, 2009). However, our use of dominant negatives, which inhibit the family by forming heterodimers (Ueno et al., 1992), suggests that one or more family members is important for migration. Moreover, each family member has the ability to rescue Rap1‐inhibited neurons. They thus act interchangeably under these conditions. The Wikipedia definition of genetic redundancy is “situations where a given biochemical function is redundantly encoded by two or more genes”. However, since we have not been able to formally prove that each family member functions in multipolar migration when expressed at endogenous level in vivo, we now say the evidence “suggests” that the FGFR family members act redundantly.

Can the dominant negative FGFR dimerize with receptors other than FGFR family members or N-Cad? Such interactions could contribute to the phenotypes observed.

The dominant‐negative mutants that were used have an intact extracellular domain but truncated cytoplasmic domain. They have the potential to interfere with endogenous FGFRs by competing for extracellular partners, including FGFs, NCad, NCAM, L1CAM and NEGR1, or by inhibiting endogenous FGFR kinase activation by forming mixed heterodimers. However, ability of both NCad and FGFR to rescue migration of Rap1 inhibited neurons, coupled with the lack of rescue by NCadΔEC4 and the finding that dominant‐negative NCad inhibits Reelin‐induced FGFR activation in neurons makes us favor NCad as the relevant partner.

3) Does NCad-dEC4 bind to receptors other than FGFRs?

We are not aware of any studies. However, we found that NCadΔEC4 still formed homophilic dimers with NCad, so it is not grossly misfolded.

4) Assays to identify binding partners, e.g. IP/mass spec experiments using lysates from primary cortical neurons expressing the dominant negative FGFR and NCad-dEC4 proteins, would be more informative.

In a different set of experiments, we did undertake large scale mass spec screens for neuronal proteins that bind NCad^W161A (the mutant that does not form trans homodimers) but not ECad. We used both BioID (with extracellular BirA) and affinity purification mass spec. Neither screen detected additional cell surface receptors.

5) While the HEK293T cells are a great starting point for the biochemistry, it is critical to perform the protein interaction and expression assays using purified cortical neurons or at least cultured primary cortical neurons. The fact that these changes, or lack of changes in some cases, occur in HEK293T cells does not guarantee that this is the case in post-mitotic cortical neurons.

The interaction, ubiquitination and protein degradation experiments were indeed performed in HEK293T cells because this kind of approach is very difficult in cultured neurons. HEK293T cells share features with neurons and are easy to transfect (Shaw et al., 2002). Nevertheless, we have added new data to the paper showing that endogenous FGFR1 protein level increases when NCad is overexpressed in cultured cortical neurons (new Figure 3C), that inhibiting Rap1 in neurons in utero decreases FGFR protein level (new Figure 3B) and that the effect of Reelin on FGFRs in cortical neurons depends on NCad and Rap1 (new Figure 8D).

6) There appears to be a disconnect between the Rap1/CDH2/FGFR and Reelin/FGFR/ERK1 and 2 signaling pathways in this manuscript that are bridged by the following sentence and the authors' previous paper "The Rap1-dependent upregulation of NCad is triggered by Reelin, an extracellular ligand present in the MMZ (Jossin and Cooper, 2011)". This needs to be more clearly stated.

We agree that the link was unclear. We have performed a new experiment which demonstrates that NCad is important for the effect of Reelin on FGFR protein level and Erk phosphorylation (Figure 8D).

7) Why is there no control image for Figure 1B to show the Golgi orientation of control cells?

A control image has been added.

8) Figure 2A and 3D: Why is FGFR expression not visible in all lanes on the WB when the protein is overexpressed? If it is a matter of exposure time, it would be preferable to use longer exposures in order to see bands in all lanes that indicate FGFR expression. It would also be helpful to see loading controls like in Figure 3D.

The requested long exposure for FGFR has been added along with the loading control in new Figure 3—figure supplement 1. Long exposure for FGFR has been added to the new Figure 8A and B.

9) Figure 3A and 3B: In contrast to Figure 2C, there is no increase in FGFR1-Myc when co-expressed with NCad-HA. If the DNA concentration is adjusted as noted in the legend, it would still be expected that the NCad-HA and NCad-W161A-HA lanes show similar levels of FGFR1-Myc, which they do not. FGFR1 appears even lower when co-expressed with NCad-HA. On the other hand, NCad-dEC4, which is proposed to not interact with FGFR1, seems to increase FGFR1 expression. I would suggest to show blots with consistent data, or remove those claims in the text.

We varied the amount of FGFR DNA to compensate for FGFR stabilization by different cadherins and make sure we had enough protein to test for co‐immunoprecipitation. However, as the reviewer noted, we over‐compensated in the experiments shown. We have repeated the experiments and now show data where FGFR is equally expressed (Figure 5A, Figure 6—figure supplement 1).

10) The authors state that NCad-dEC4 does not interact with FGFR1 and is unable to rescue migration defects in Rap1GAP cells, which indicates that NCad interacts with FGFR1 through its EC4 domain. However, the data in Figure 5 shows that NCad increases FGFR1 expression and promotes neuronal migration through its EC1-2 domains. The same figure also shows that the EC4 domain-containing chimeric E/NCad does not increase FGFR or promote migration. This is confusing. If NCad does interact with FGFR1 via EC4 and promotes migration via EC1-2, it would suggest that homophilic binding of NCad or heterophilic binding to other proteins, in addition to heterophilic NCad:FGFR binding, plays a role in migration. Nevertheless, the authors present data indicating that homophilic NCad interactions do not have a role migration. These data need clarification.

This is exactly what we are claiming in this manuscript. Binding of NCad EC4 to FGFR is necessary but not sufficient to inhibit FGFR degradation. Indeed, ECad also interacts with FGFR through its EC4 but is unable to prevent FGFR degradation or promote neuronal migration in vivo. An NCad molecule containing EC4‐5 from ECad still protects FGFR from degradation and promotes neuron migration in vivo. The reciprocal switch, putting EC4 of NCad into ECad, does not give to ECad the ability to prevent FGFR degradation or to promote neuronal migration in vivo. The protection from degradation and promotion of migration map to EC1‐2 even though it needs the NCad‐FGFR interaction through EC4. This EC1‐2 function is not NCad‐NCad homophilic binding. We suggest that another protein interacting with NCad but not ECad EC1‐2 might be involved. Discovering this third partner is however beyond the scope of this manuscript.

11) Were the ERK1/2 constructs expressed in cortical neurons selectively expressed in post-mitotic cells?

Yes, we used the NeuroD promoter, as stated in the figure legend (Figure 9A).

12) The Discussion ends rather abruptly.

We thank the reviewer for the comment, and have added a concluding paragraph.

[Editors' note: the author responses to the re-review follow.]

Kon et al. revised their manuscript ʺFGFR ubiquitination and degradation controls neuronal migration in vivoʺ to reflect their observation that cortical neurons appear to stall at the multipolar stage when FGFR signaling is perturbed by transgenic expression of DN FGFR. They have done a nice job of streamlining the biochemical and in utero electroporation epistasis experiments, and performing more of the biochemical experiments in cultured cortical neurons as requested, to work out the signaling mechanism involved. While the manuscript overall has improved, there are several issues that I feel do not make it suitable for publication in eLife at this time and may be more suitable for a more specialized journal.

First, I still worry that expression of a DN FGFR, as opposed to conditional genetic loss of function experiments, may have some off-target effects. In addition, the finding by Szczurkowska et al., 2018, that FGFR2 regulates neuronal migration and spine density suggests that the FGFRs may not act redundantly.

We addressed the issue of specificity of FGFRs downregulation and overlapping functions of FGFRs in multipolar migration. We specifically knock‐down FGFR1, 2 and 3. We tested at least 6 shRNA for each receptor and selected the most efficient. The efficiency of the shRNAs was tested in cell culture and in vivo as explained in Figure 1—figure supplement 1.

We found that the in vivo knock‐down of FGFR1 and 2 induces an arrest of cells at the MMZ, with a more pronounced phenotype when the two receptors are downregulated together (Figure 1B). The knock‐down of FGFR3 resulted in a small, statistically non‐significant effect on cell positioning (Figure 1B). These results suggest that FGFRs work redundantly with a prominent role for FGFR1 and FGFR2.

Reviewer #2 was also concerned that FGFR(DN) could affect NCad. We found that in cell culture, FGFR(DN) does not change NCad protein expression level, does not reduce NCad homophilic interaction and does not prevent NCad accumulation at cell‐cell junctions (Figure 3—figure supplement 1B).

Second, I do not agree that the terminology "multipolar migration" is justified without more detailed analysis of the cellular mechanism involved. Better high magnification/resolution images of cell morphology at this stage, combined with live imaging, would be required to determine why and how these cells are stalling.

To gain insight into the mechanism underlying the migration defect, we analyzed the morphology of migrating neurons. Analysis of the morphology revealed no difference in the number of neurites or in the cell body length‐to‐width ratio of FGFR‐inhibited multipolar neurons compared to control multipolar neurons

(Figure 2B-D). In addition, the few FGFR‐inhibited bipolar neurons migrating in the RMZ exhibited no difference in the length of the leading process and the cell body length‐to‐width ratio compared to control cells and possess an axon at the rear (Figure 2G=I).

Author details

1. Elif Kon

   Laboratory of Mammalian Development & Cell Biology, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium

   Contribution

   Data curation, Formal analysis, Validation, Investigation, Visualization, Performed most of the biochemistry and histology experiments, Assisted with preparing the manuscript

   Competing interests

   No competing interests declared

2. Elisa Calvo-Jiménez

   Laboratory of Mammalian Development & Cell Biology, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium

   Contribution

   Data curation, Formal analysis, Validation, Investigation, Visualization, Assisted with the biochemistry and histology experiments, Performed the primary cortical neuron nucleofection experiments, Assisted with preparing the manuscript

   Competing interests

   No competing interests declared

3. Alexia Cossard

   Laboratory of Mammalian Development & Cell Biology, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium

   Contribution

   Investigation, Visualization, Assisted with the biochemistry and histology experiments, Assisted with preparing the manuscript

   Competing interests

   No competing interests declared

4. Youn Na

   Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, United States

   Contribution

   Investigation, Assisted with the biochemistry and histology experiments, Assisted with preparing the manuscript

   Competing interests

   No competing interests declared

5. Jonathan A Cooper

   Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, United States

   Contribution

   Writing—review and editing, Reviewed and edited the final version of the manuscript, Assisted with preparing the manuscript

   Competing interests

   Senior editor, eLife

   "This ORCID iD identifies the author of this article:" 0000-0002-8626-7827

6. Yves Jossin

   Laboratory of Mammalian Development & Cell Biology, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium

   Contribution

   Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing, Conceived and supervised the project, Designed all experiments, Wrote the original draft of the manuscript, Reviewed and edited the final version of the manuscript, Performed the in vivo experiments

   For correspondence

   yves.jossin@uclouvain.be

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-8466-7432

• 2,467

  Page views

• 424

  Downloads

• 20

  Citations

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.